Phebra Acquires Equity Stake in UK Specialty Hospital Pharma Company Flexipharm Austrading
– Phebra takes part ownership of Flexipharm Austrading through share purchase
– Builds on Phebra’s Existing UK Distribution Agreement
– Strengthens Phebra’s Presence in UK and Europe
SYDNEY and BOURNE END, England, Nov. 3, 2021 /PRNewswire/ — Leading Australian pharmaceutical group Phebra Holdings (‘Phebra’) is pleased to announce that it has completed a share purchase agreement with the UK hospital specialty pharmaceutical company Flexipharm Austrading Limited (‘FAL’).
